Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report

Immune checkpoint inhibitors (ICIs) have been shown to improve survival in patients with advanced or metastatic esophageal cancer. However, ICI‐based rechallenges after recovery from fatal adverse events (AEs) are equivocal, especially in patients who have already undergone treatment‐related AEs. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yanhong, Liu, Zhentao, Li, Qian, Cao, Baoshan, Wang, Mopei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807265/
https://www.ncbi.nlm.nih.gov/pubmed/35014762
http://dx.doi.org/10.1111/1759-7714.14279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807265/
https://www.ncbi.nlm.nih.gov/pubmed/35014762
http://dx.doi.org/10.1111/1759-7714.14279

Ejemplares similares